Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $52 Price Target

Benzinga Newsdesk www.benzinga.com Negative 83.0%

Neg 83% Neu 0% Pos 0%

Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $52 price target.